Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ticagrelor vs DAPT for Platelet Reactivity After TAVI
NCT02224066Phase 4Completed
- Sponsor
- Hospital do Meixoeiro
- Start
- Jan 2016
- Primary completion
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of ticagrelor in aortic valve stenosis (3 arms), sponsored by Hospital do Meixoeiro. Primary endpoint: Residual platelet reactivity by VerifyNow P2Y12 assay at 3 months. Started Jan 2016; status: completed.
02
Drugs
ticagrelor
03
Conditions
aortic valve stenosis
Beyond the preview
Go deeper on NCT02224066.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02224066.